BURJEEL HOLDINGS PLC

Logotype for BURJEEL HOLDINGS PLC
Ticker/ISIN
BURJEEL
AEE01119B224
Market/Country
Abu Dhabi Stock Exchange
United Arab Emirates
Latest Stock Price
3.24 AED
2024-02-21

Year to date

0.04 %

3 months

0.00 %

6 months

0.00 %

1 year

0.00 %

3 years

0.00 %

5 years

0.00 %

The Group is one of the leading regional private healthcare service providers in the UAE and Oman, operating as an integrated network across primary, secondary, tertiary and quaternary medical care services. The Group provides a comprehensive healthcare ecosystem to patients across the full socio-economic spectrum through its four key market leading brands, Burjeel, Medeor, LLH and Lifecare, and its fully-funded network of 16 hospitals, 23 medical centres (including polyclinics and specialty medical centres with dental, cosmetic, homecare services, a specialised orthopaedics centre and IVF centres) and 15 pharmacies, as well as seven entities conducting allied services such as central procurement (e.g., GPO), revenue cycle management, centralised diagnostics, central warehousing and patient valet parking services. Leveraging its clinical expertise and strengths in research and development, the Group will also provide medical education and research through its College of Medicine at BMC, beginning in 2023. The Group is a leading healthcare provider in the UAE private market, with an in-patient market share of approximately 17 per cent. and an out-patient market share of approximately 12 per cent. and a total in-patient admission bed capacity of 1,294 beds as at 30 June 2022. The Group treated 105 thousand in-patients and 4.8 million out-patients in 2021 across its network, with comprehensive service offerings for oncology, women and child, orthopaedics and spine, cardiac science and bariatrics. BMC is also the only European Society for Medical Oncology-accredited cancer centre in the UAE and the largest private hospital in the UAE. The quality of the Group’s portfolio of medical facilities is evidenced by its operating 12 hospitals with JCI accreditations, three hospitals with ISOC 9001:2015 certifications and eight labs with ISO 15189:2012 certifications.

Latest Pressrelease Summaries

Axiom Space and Burjeel Holdings have signed a Memorandum of Understanding to conduct scientific research and test new technologies in space, focusing on how the human body reacts in microgravity. The collaboration aims to expand access to microgravity for medical advancements. The announcement was made at a signing ceremony in New York, attended by key executives from both organizations. As their first initiative, they plan to send a suite of medical capabilities to space, which will be used by Axiom Space astronauts during their training and the upcoming Axiom Mission 4 (Ax-4). This research will study the effects of microgravity on biomarkers, drug substance quality, and remote health services. The partnership is intended to benefit medical innovation and patient outcomes globally, aligning with the UAE's vision for space exploration.
Burjeel Holdings PLC, a leading healthcare provider in the MENA region, has announced plans to expand its women and children healthcare services by launching IVF services. This expansion will be integrated into their existing comprehensive portfolio, which includes advanced gynecology, fetal medicine, and pediatric subspecialties. The Trust Fertility Clinic, part of Burjeel Medical City, will be the largest fertility center in the UAE, offering advanced personalized fertility care and cutting-edge technologies such as AI-driven embryo selection. The clinic will be led by Dr. Walid Sayed, an expert in reproductive endocrinology and infertility. This initiative aims to provide a seamless journey for women from conception to delivery, ensuring high standards of care for both maternal and newborn health. The expansion reflects Burjeel's commitment to meeting the growing demand for fertility services in the region and providing world-class, personalized care.
Abu Dhabi Stem Cells Center (ADSCC) and Burjeel Holdings PLC have formed a strategic partnership to expand bone marrow transplant and cellular therapy services at Burjeel Medical City (BMC). This collaboration aims to enhance access to advanced care for patients with blood cancer, genetic diseases, autoimmune diseases, and other conditions, establishing Abu Dhabi as a global healthcare destination. ADSCC will extend its proprietary Abu Dhabi Bone Marrow Transplant Program (AD-BMT©) to BMC, which is accredited by the Department of Health - Abu Dhabi and recognized by the Foundation for the Accreditation of Cellular Therapy (FACT). ADSCC has achieved significant milestones in bone marrow transplantation and CAR-T Cell Therapy since 2020. The Burjeel Cancer Institute (BCI) at BMC has also pioneered bone marrow transplants, including the UAE’s first pediatric BMT in 2022. The partnership aims to create an integrated ecosystem for advanced research, cellular therapy, and regenerative medicine, benefiting new and existing patients. Both institutions are committed to setting new benchmarks in patient outcomes and medical excellence.
Burjeel Holdings PLC, a leading healthcare services provider in the MENA region listed on the Abu Dhabi Securities Exchange, has been included in the FTSE Global Equity Index Series - Middle East & Africa following the latest semi-annual review. The changes will be effective after market close on September 20, 2024, and will be reflected from September 23, 2024. Burjeel's inclusion in several FTSE indices highlights its importance in the UAE capital markets and is expected to enhance investor confidence and visibility among global institutional investors. The FTSE Global Equity Index Series includes over 19,000 securities across 49 markets globally. Founded in 2007, Burjeel operates 89 assets across the UAE, Oman, and Saudi Arabia, including hospitals, medical centers, pharmacies, and other services.
Burjeel Holdings PLC, a leading healthcare services provider in MENA, has received a provisional "AAA" ESG rating from MSCI, placing it among the top 6% of global healthcare leaders in environmental, social, and governance performance. This rating highlights Burjeel’s effective management of ESG-related risks and opportunities, including reducing environmental impact, ensuring safety and quality in healthcare services, strong labor management, and robust privacy and data protection measures. The recognition aligns with the UAE's vision for sustainable socioeconomic development. Burjeel's new long-term ESG strategy focuses on promoting well-being, sustainability, and carbon neutrality by 2040. The Group has already achieved significant milestones, including awards for diversity, inclusion, and sustainable practices.
Burjeel Holdings PLC, a leading super-specialty healthcare services provider in the MENA region listed on the Abu Dhabi Securities Exchange, reported double-digit revenue growth for the first half of 2024. The Group's revenue increased by 10% to AED 2.4 billion, driven by a 6% rise in patient footfall and improvements in patient yield. Burjeel Medical Center (BMC) saw a 21% growth in top-line revenue, with patient footfall reaching 3.1 million in H1'24 and accelerating to 11% in Q2'24. BMC's EBITDA rose by 41% to AED 93 million, while the hospitals' EBITDA grew by 9% to AED 464 million, reflecting strong growth in oncology and other advanced specialty services. The hospitals' net profit improved by 24% to AED 253 million due to growth asset ramp-up and cost optimization. Burjeel Holdings also launched IMed Technologies to create AI-based health tech solutions, aiming to enhance patient care, provider satisfaction, and financial performance.
The Board of Directors of Burjeel Holdings PLC virtually convened on 07/05/2024 at 5:00 PM UAE time. The board reviewed and approved the company's financial statements for the first quarter of the financial year 2024. They also discussed other business matters that have no effect on the share price. The meeting was led by the company's Chief Executive Officer, John Sunil. The Securities and Commodities Authority (SCA) was also copied on this correspondence.
Burjeel Holdings PLC, a leading healthcare services provider in the Middle East and North Africa (MENA) region, reported double-digit revenue growth for Q1 2024. The group's revenue grew by 11% to AED 1.2 billion, with a net profit of AED 141 million, an increase of 16%. This growth was attributed to increased operational efficiencies, lower finance costs, and the early start of Ramadan. The company also reported a 22% increase in BMC revenue to AED 283 million, driven by higher patient footfall and the expansion of super-specialty services. The company continues to invest in complex care and aims to expand its healthcare infrastructure.

Threads

Page 1
Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

Axiom Space and Burjeel Holdings have signed a Memorandum of Understanding to conduct scientific research and test new technologies in space, focusing on how the human body reacts in microgravity. The collaboration aims to expand access to microgravity for medical advancements. The announcement was made at a signing ceremony in New York, attended by key executives from both organizations. As their first initiative, they plan to send a suite of medical capabilities to space, which will be used by Axiom Space astronauts during their training and the upcoming Axiom Mission 4 (Ax-4). This research will study the effects of microgravity on biomarkers, drug substance quality, and remote health services. The partnership is intended to benefit medical innovation and patient outcomes globally, aligning with the UAE's vision for space exploration.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

Burjeel Holdings PLC, a leading healthcare provider in the MENA region, has announced plans to expand its women and children healthcare services by launching IVF services. This expansion will be integrated into their existing comprehensive portfolio, which includes advanced gynecology, fetal medicine, and pediatric subspecialties. The Trust Fertility Clinic, part of Burjeel Medical City, will be the largest fertility center in the UAE, offering advanced personalized fertility care and cutting-edge technologies such as AI-driven embryo selection. The clinic will be led by Dr. Walid Sayed, an expert in reproductive endocrinology and infertility. This initiative aims to provide a seamless journey for women from conception to delivery, ensuring high standards of care for both maternal and newborn health. The expansion reflects Burjeel's commitment to meeting the growing demand for fertility services in the region and providing world-class, personalized care.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

Abu Dhabi Stem Cells Center (ADSCC) and Burjeel Holdings PLC have formed a strategic partnership to expand bone marrow transplant and cellular therapy services at Burjeel Medical City (BMC). This collaboration aims to enhance access to advanced care for patients with blood cancer, genetic diseases, autoimmune diseases, and other conditions, establishing Abu Dhabi as a global healthcare destination. ADSCC will extend its proprietary Abu Dhabi Bone Marrow Transplant Program (AD-BMT©) to BMC, which is accredited by the Department of Health - Abu Dhabi and recognized by the Foundation for the Accreditation of Cellular Therapy (FACT). ADSCC has achieved significant milestones in bone marrow transplantation and CAR-T Cell Therapy since 2020. The Burjeel Cancer Institute (BCI) at BMC has also pioneered bone marrow transplants, including the UAE’s first pediatric BMT in 2022. The partnership aims to create an integrated ecosystem for advanced research, cellular therapy, and regenerative medicine, benefiting new and existing patients. Both institutions are committed to setting new benchmarks in patient outcomes and medical excellence.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

Burjeel Holdings PLC, a leading healthcare services provider in the MENA region listed on the Abu Dhabi Securities Exchange, has been included in the FTSE Global Equity Index Series - Middle East & Africa following the latest semi-annual review. The changes will be effective after market close on September 20, 2024, and will be reflected from September 23, 2024. Burjeel's inclusion in several FTSE indices highlights its importance in the UAE capital markets and is expected to enhance investor confidence and visibility among global institutional investors. The FTSE Global Equity Index Series includes over 19,000 securities across 49 markets globally. Founded in 2007, Burjeel operates 89 assets across the UAE, Oman, and Saudi Arabia, including hospitals, medical centers, pharmacies, and other services.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC General Press Release

Burjeel Holdings PLC, a leading healthcare services provider in MENA, has received a provisional "AAA" ESG rating from MSCI, placing it among the top 6% of global healthcare leaders in environmental, social, and governance performance. This rating highlights Burjeel’s effective management of ESG-related risks and opportunities, including reducing environmental impact, ensuring safety and quality in healthcare services, strong labor management, and robust privacy and data protection measures. The recognition aligns with the UAE's vision for sustainable socioeconomic development. Burjeel's new long-term ESG strategy focuses on promoting well-being, sustainability, and carbon neutrality by 2040. The Group has already achieved significant milestones, including awards for diversity, inclusion, and sustainable practices.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Board Meeting Results held on 07/08/2024 at 17:00

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Management Discussion and Analysis Report for the Period Ended June 30,2024

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Financial Results for the Period Ended June 30,2024

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Press Release on the Financial Results for the Period Ended June 30,2024

Burjeel Holdings PLC, a leading super-specialty healthcare services provider in the MENA region listed on the Abu Dhabi Securities Exchange, reported double-digit revenue growth for the first half of 2024. The Group's revenue increased by 10% to AED 2.4 billion, driven by a 6% rise in patient footfall and improvements in patient yield. Burjeel Medical Center (BMC) saw a 21% growth in top-line revenue, with patient footfall reaching 3.1 million in H1'24 and accelerating to 11% in Q2'24. BMC's EBITDA rose by 41% to AED 93 million, while the hospitals' EBITDA grew by 9% to AED 464 million, reflecting strong growth in oncology and other advanced specialty services. The hospitals' net profit improved by 24% to AED 253 million due to growth asset ramp-up and cost optimization. Burjeel Holdings also launched IMed Technologies to create AI-based health tech solutions, aiming to enhance patient care, provider satisfaction, and financial performance.

1. Attached Document

Abu Dhabi Stock Exchange News

Abu Dhabi Stock Exchange News

News Update From BURJEEL HOLDINGS PLC

Disclosures: BURJEEL HOLDINGS PLC Announcement of Board Meeting to be held on 07/08/2024 at 17:00

1. Attached Document

Page 1